Abstract
The PV market was valued at roughly $1.9 billion in 2006 and will increase at
a rapid CAGR of over 10% throughout the forecast period.
The peripheral vascular (PV) device market comprises PV stents, percutaneous
transluminal angioplasty (PTA) balloon catheters, embolic protection devices
(EPDs), inferior vena cava filters (IVCFs), aortic stent grafts, synthetic
surgical grafts, and accessory devices.
View Cart
